LYCOS RETRIEVER 
Advair: Advair Hfa
built 645 days ago
Advair HFA is approved for the long-term, twice-daily maintenance treatment of asthma in patients 12 years of age and older. Because LABAs may increase the risk of asthma-related death, Advair is for patients not adequately controlled on other asthma-controller medications (e.g., low- to medium-dose inhaled corticosteroids) or whose disease severity clearly warrants initiation of treatment with two maintenance therapies. Advair is not approved for patients whose asthma can be successfully managed with an ICS along with occasional use of short-acting beta-agonists. Advair is not indicated for the relief of acute bronchospasm.
Source:
Advair HFA is an aerosol form of fluticasone and salmeterol that comes in a canister that is used with an actuator inhaler device. Use only the inhaler device provided with Advair HFA. This device is not to be used with a spacer.
Source:
Seretide (Advair) inhaler contains a suspension of salmeterol xinafoate and fluticasone propionate in CFC-free propellant, HFA 134a. The medicine is contained in a pressurised can, with a mouthpiece and an 'actuator'. Each time the actuator is pressed a dose of the medicine is released. Each can contains 120 doses of the medicine. Each dose contains 25 micrograms (mcg) salmeterol (as xinafoate) and 50, 125 or 250 mcg fluticasone propionate.
Source:
Advair HFA and certain other medicines may interact with each other. Tell your healthcare professional about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your healthcare professional if you take ritonavir. The anti-HIV medicines Norvir and Kaletra contain ritonavir.
Source:
Advair HFA is used in the treatment of asthma. Advair HFA contains fluticasone propionate, an inhaled corticosteroid medicine. Inhaled corticosteroids help to decrease inflammation in the lungs. Inflammation in the lungs can lead to asthma symptoms. It ... contains salmeterol inhalation powder, a long-acting beta-agonist (LABA) medicine. LABAs help to relax the muscles around the airways in your lungs.
Source:
Advair HFA was developed and is marketed by GlaxoSmithKline, a research-based pharmaceutical and a world leader in respiratory care. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information on GlaxoSmithKline visit http://www.gsk.com.
Source:
MORE ABOUT
Advair Hfa